Furthermore, pro‐inflammatory IL‐6 which has been reported to be a critical modulator of cancer progression was significantly upregulated in the miR‐223‐high group, whereas the IL‐6R level was not different between miR‐223‐high and miR‐223‐low groups (Fig. 7B). The gene discussed is IL6R; the disease is cancer.